People · Operator
Named in public records as an officer, director or promoter · active 2016–2024 · Software / Tech, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Valon Technologies, Inc. | — | Software / Tech | Series C | $161.4M | $639.0M | 2019 |
| Capio Biosciences, Inc. | — | Biotechnology | Seed | $2.9M | $128.8M | 2016 |
Andrew Wang at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Andrew Wang on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Chen | 1 | 6 |
| Brian McGrath | 1 | 5 |
| Ilan Stern | 1 | 4 |
| Angela Strange | 1 | 3 |
| Timothy Mayopoulos | 1 | 2 |
| Fenlai Tan | 1 | 1 |
| Seungpyo Hong | 1 | 1 |
| Max Fink | 1 | 1 |
| Joshua Dart | 1 | 1 |
| Tim Mayopoulos | 1 | 1 |
| Susie Xu | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.